In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.
about
Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule deliveryClinical and research applications of simultaneous positron emission tomography and MRIPotential clinical applications of bimodal PET-MRI or SPECT-MRI agentsRadiolabeled theranostics: magnetic and gold nanoparticlesRadioactive Nanomaterials for Multimodality ImagingMultimodality and nanoparticles in medical imagingTumor lysing genetically engineered T cells loaded with multi-modal imaging agentsRadiolabeling of Nanoparticles and Polymers for PET ImagingThe use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.Development and applications of radioactive nanoparticles for imaging of biological systems.Inorganic nanoparticle-based contrast agents for molecular imagingNoninvasive MRI-SERS imaging in living mice using an innately bimodal nanomaterial.PET Imaging and Biodistribution of Silicon Quantum Dots in Mice.Self-assembly of phospholipid-PEG coating on nanoparticles through dual solvent exchange.In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agentsMagnetically Decorated Multi-Walled Carbon Nanotubes as Dual MRI and SPECT Contrast AgentsNanoparticles labeled with positron emitting nuclides: advantages, methods, and applications.In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesSimultaneous PET-MRI in oncology: a solution looking for a problem?Development of a Hybrid Nanoprobe for Triple-Modality MR/SPECT/Optical Fluorescence Imaging.Biodistribution and fate of core-labeled 125I polymeric nanocarriers prepared by Flash NanoPrecipitation (FNP).Engineering of radiolabeled iron oxide nanoparticles for dual-modality imagingMembrane mimetic surface functionalization of nanoparticles: methods and applicationsCompetitive advantage of PET/MRI.Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.Chelator-free synthesis of a dual-modality PET/MRI agent.Multimodality PET/MRI agents targeted to activated macrophages.Real-time in vivo monitoring of magnetic nanoparticles in the bloodstream by AC biosusceptometrySynthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment.The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.Strategies for in vivo imaging of enzyme activity: an overview and recent advances.Strategies in biomimetic surface engineering of nanoparticles for biomedical applications.Nanoprobes for hybrid SPECT/MR molecular imaging.Engineering imaging probes and molecular machines for nanomedicine.Engineering multifunctional nanoparticles: all-in-one versus one-for-all.Nanoparticle-based multimodal PET/MRI probes.Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agentMain applications of hybrid PET-MRI contrast agents: a review.The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.
P2860
Q26830434-00807961-F644-4D98-B011-D7A1C02BF16EQ26998774-67040138-E205-418D-8F47-0C8CF4F54502Q27026301-80A76390-8421-4A24-9035-8BEE86654C9CQ28074696-3B4F78DC-6381-4B33-9E76-B3F3792F1961Q28833646-6965F0F9-3018-4A3C-9021-EBC089EE3269Q30407070-648E544B-7A11-4834-9C56-C7D74612EA33Q30441151-BD470A87-3DA4-431D-8A9B-642A442F14A4Q33584719-D64E1904-67D1-4BA7-8CFD-856D767C1E0AQ33823191-C0867AB0-2698-4E97-AFF3-403A56A0F158Q33834952-83418F09-ED39-4FE4-9428-AA6A7CDB87CDQ34437253-9A889B91-AEDF-4B36-B7BE-E09926AA7B96Q34644628-350C1A21-214D-484F-B112-C1D7096E244AQ34807017-C641E65F-87D1-49E6-9C36-E98B97D2D12FQ34909815-184C55D7-A585-412A-BD8C-C7176B576E7AQ35214397-42F0C878-5A9B-4C33-9D50-C8563101817FQ35232459-AE152541-CE06-41A9-AF7C-B712411A3245Q35752904-C2326DA5-21AC-461D-BFCB-310592E8089AQ35897573-4FACE1B1-37C4-4DA0-A342-7F723DD3644EQ36289257-B0D0B9E0-1957-44E8-99B6-54300FB98E59Q36303648-110EAC7D-4CE9-4751-A13B-7420C944EF87Q36335080-E3889AF2-01E0-48C5-A8CF-F1F043D53041Q36783691-7AAF05A0-0155-46B8-8EC8-CF1C434273FBQ37014204-C977E828-8B4B-4F55-B8B5-A16408CB8167Q37060172-148321C0-12D2-406A-A918-4DA3B46E4440Q37238715-9EB5ACC7-308D-4268-A35C-720D5D6D38D6Q37356037-0C28787C-0E63-4B96-83CD-2356E1F5E9BDQ37374640-008A0344-4AF1-4905-A444-079A97169F46Q37625234-0100E7A3-B681-4606-9A7B-FA8EBC43F44FQ37715749-F773AAF5-5D73-4F09-8E0F-C40DD66306BCQ37848104-3E5D435A-C18D-4588-8D57-F1483BCD0C3FQ37869905-7F1593FC-ACBC-410A-8A70-A0BEFE71E697Q37873318-62433E0D-DEC0-4365-B5F1-6DA1885890D6Q37963778-AFC78774-5A40-47F1-991C-03A62E5CE08CQ38013146-946D7EBB-49C6-4F5E-8057-CF3B2EB3511BQ38056410-72B5BC07-370C-4B9C-9DA7-EB33155864EEQ38085594-406E7C94-DF24-4F45-B99C-120CBD9E54FBQ38467265-CF2F3FB3-6BE5-4260-A871-65CB2E8B20E1Q38559085-76F1026E-07DF-4036-BF71-69BC1D89AA07Q38657496-90ACCC02-B79C-4EEA-A965-7A38D2C240C7Q38784932-A0C727D7-83F0-4F36-AABF-E2683FF365D7
P2860
In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
In vivo evaluation of (64)Cu-l ...... modality PET/MR imaging agent.
@ast
In vivo evaluation of (64)Cu-l ...... modality PET/MR imaging agent.
@en
type
label
In vivo evaluation of (64)Cu-l ...... modality PET/MR imaging agent.
@ast
In vivo evaluation of (64)Cu-l ...... modality PET/MR imaging agent.
@en
prefLabel
In vivo evaluation of (64)Cu-l ...... modality PET/MR imaging agent.
@ast
In vivo evaluation of (64)Cu-l ...... modality PET/MR imaging agent.
@en
P2093
P2860
P356
P1476
In vivo evaluation of (64)Cu-l ...... modality PET/MR imaging agent.
@en
P2093
Charles Glaus
Michael J Welch
Raffaella Rossin
P2860
P304
P356
10.1021/BC900511J
P577
2010-04-01T00:00:00Z